Lista de obras -

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology

artículo científico publicado en 2022

A sequential methodology for the rapid identification and characterization of breast cancer-associated functional SNPs

artículo científico publicado en 2020

Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

artículo científico publicado en 2015

Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover

artículo científico publicado en 2015

Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions

artículo científico publicado en 2021

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

artículo científico publicado en 2021

Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures

scientific article published on 18 September 2018

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance

artículo científico publicado en 2017

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation

artículo científico publicado en 2022

Estrogen receptor alpha mutations in breast cancer cells cause gene expression changes through constant activity and secondary effects

artículo científico publicado en 2020

FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype

scientific article published on 27 June 2019

Frequent ESR1 and CDK Pathway Copy Number Alterations in Metastatic Breast Cancer

article

Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.

artículo científico publicado en 2016

Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer

artículo científico publicado en 2013

Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment

scientific article published in 2023

Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade

scientific article published on 15 August 2018

Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism.

artículo científico publicado en 2018

Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer

artículo científico publicado en 2018

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities

artículo científico publicado en 2022

Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models.

artículo científico publicado en 2017

Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer

artículo científico publicado en 2022

Publisher Correction: Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment

scientific article published in 2023

Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer

artículo científico publicado en 2022

SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma

scientific article published on 23 February 2019

Single-cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells

scientific article published on 04 November 2020

Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations

artículo científico publicado en 2024

Steroid hormone receptor and infiltrating immune cell status reveals therapeutic vulnerabilities of ESR1 mutant breast cancer

artículo científico publicado en 2020

The dysregulated pharmacology of clinically relevant ESR1 mutants is normalized by ligand-activated WT receptor

scientific article published on 07 May 2020

Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes

artículo científico publicado en 2012

Lista de obras de

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology

A sequential methodology for the rapid identification and characterization of breast cancer-associated functional SNPs

Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover

Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation

Estrogen receptor alpha mutations in breast cancer cells cause gene expression changes through constant activity and secondary effects

FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype

Frequent ESR1 and CDK Pathway Copy Number Alterations in Metastatic Breast Cancer

Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.

Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer

Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment

Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade

Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism.

Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities

Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models.

Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer

Publisher Correction: Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment

Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer

SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma

Single-cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells

Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations

Steroid hormone receptor and infiltrating immune cell status reveals therapeutic vulnerabilities of ESR1 mutant breast cancer

The dysregulated pharmacology of clinically relevant ESR1 mutants is normalized by ligand-activated WT receptor

Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes